Cott Corporation Completes US$149.9M Bought Deal Offering
Goodmans represented Cott Corporation ("Cott") in connection with the completion of a public offering of 16,215,000 common shares at a price of US$9.25 per share on a bought deal basis, which includes the exercise in full by the underwriters of their over-allotment option to purchase an additional 2,115,000 common shares, for total gross proceeds to Cott of US$149,988,750.
Cott will use the net proceeds of this offering to redeem all of Cott's Series B Non-Convertible First Preferred Shares and a portion of Cott's Series A Convertible First Preferred Shares.
The common shares were offered in the United States pursuant to a prospectus supplement dated May 27, 2015, to Cott's effective registration statement dated May 26, 2015, filed with the U.S. Securities and Exchange Commission, and in each of the Provinces of Canada, except Quebec, by way of a prospecuts supplement dated May 27, 2015 to Cott's short form base shelf prospectus dated May 19, 2015.
Cott is on of the world's largest producers of beverages on behalf of retailers, brand owners and distributors.
Expertise
Featured Work
-
Capital Markets
Apotex Health Corp. closes $1.25 billion inaugural senior unsecured notes offering
Goodmans LLP acted for Apotex Health Corp. in connection with its private placement offering of $1.25 billion aggregate principal amount of senior unsecured notes… -
Entertainment
WildBrain announces a C$20 million substantial issuer bid
Goodmans LLP is acting for WildBrain Ltd. in connection with its substantial issuer bid to purchase, for cancellation, a number of common shares of the company for an aggregate purchase price not… -
Communications and Media
Sangoma Technologies to be acquired by BRC Group Holdings, Inc.
Goodmans LLP is acting for Sangoma Technologies Corporation in connection with a definitive arrangement agreement pursuant to which an affiliate of BRC Group Holdings will acquire all of the issued… -
Capital Markets
Apotex Health Corp. completes upsized $850 million bought deal secondary offering
Goodmans LLP acted for Apotex Health Corp. in connection with the closing of the upsized bought deal secondary offering of its common shares by an affiliate of SK Capital Partners, API Investment LP… -
Mergers and Acquisitions
WildBrain acquires Personality AI
Goodmans LLP acted for WildBrain Ltd. in connection with its acquisition of Personality AI, a trusted, kid-safe partner for bringing beloved character experiences to life through proprietary… -
Mergers and Acquisitions
Thoma Bravo acquires Kneat Solutions for C$650 million
Goodmans LLP advised Thoma Bravo, L.P., the largest software-focused investment firm in the world, in connection with its acquisition of Kneat Solutions for C$650 million in an all-cash take-private…